{
  "hits": 206,
  "size": 50,
  "data": [
    {
      "title": "2021年净利预计同比增长50%至73%，好于预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2022-01-13 00:00:00.000",
      "infoCode": "AP202201131540220189",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "3.21",
      "predictLastYearPe": "37",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗服务",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "147.0000000000",
      "indvAimPriceL": "147.0000000000",
      "attachType": "0",
      "attachSize": 508,
      "attachPages": 3,
      "encodeUrl": "2Ko5Zru839xcT28p0noGnyiA/S2NMrTkUIiAwkxdSPo=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2021三季报点评：业绩高速增长，研发支撑长期发展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2021-10-26 00:00:00.000",
      "infoCode": "AP202110261525109860",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 394,
      "attachPages": 4,
      "encodeUrl": "ll7KmuXTAw8+9TBOTg0DH6S35uyEbwAQ7K72VhAI/wU=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHENZHEN",
      "authorID": [
        "11000177532"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Impressive backlog growth momentum and enhancing global competence",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80027629",
      "orgName": "CMB International Securities Limited",
      "orgSName": "招银国际",
      "publishDate": "2021-10-26 00:00:00.000",
      "infoCode": "AP202110261525091529",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000305338.Jill Wu"
      ],
      "indvIsNew": "001",
      "researcher": "Jill Wu",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "212.5900000000",
      "indvAimPriceL": "212.5900000000",
      "attachType": "0",
      "attachSize": 1002,
      "attachPages": 4,
      "encodeUrl": "ll7KmuXTAw8+9TBOTg0DH5+fJyndb6M/NcS39sQtxDg=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000305338"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2021三季报点评：主营业务持续复苏 Q3实现快增",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2021-10-25 00:00:00.000",
      "infoCode": "AP202110251524880198",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 447,
      "attachPages": 3,
      "encodeUrl": "wH0Yrjq6Q6IWqq+40jpnk2VLdLrl6dDoB8Bfp+DGdsI=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000179188"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "公司点评报告：三季报业绩超预期，公司业务加速恢复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80092742",
      "orgName": "信达证券股份有限公司",
      "orgSName": "信达证券",
      "publishDate": "2021-10-25 00:00:00.000",
      "infoCode": "AP202110251524861401",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000258545.周平"
      ],
      "indvIsNew": "001",
      "researcher": "周平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 880,
      "attachPages": 5,
      "encodeUrl": "wH0Yrjq6Q6IWqq+40jpnk+vPcAMfq7zkbHeJ4eMnSe4=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHENZHEN",
      "authorID": [
        "11000258545"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩增长超预期，国际化值得期待",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-10-25 00:00:00.000",
      "infoCode": "AP202110251524843843",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 991,
      "attachPages": 4,
      "encodeUrl": "wH0Yrjq6Q6IWqq+40jpnkwU8UXOfk9E/XqD0wJ8+Oa8=",
      "sRatingName": "持有",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000254058"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "订单充裕，将持续受益于医药行业研发景气",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券",
      "orgSName": "群益证券",
      "publishDate": "2021-09-28 00:00:00.000",
      "infoCode": "AP202109281519145684",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000208428.曾永坚",
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "曾永坚,王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "206.0000000000",
      "indvAimPriceL": "206.0000000000",
      "attachType": "0",
      "attachSize": 577,
      "attachPages": 4,
      "encodeUrl": "Ijlt2dYDH6Jg0ovYrMadf7U0ZDrmiYAD5jgrQhL/X3g=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000208428",
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "公司点评报告：主营业务加速恢复，海外拓展推动转型升级",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80092742",
      "orgName": "信达证券股份有限公司",
      "orgSName": "信达证券",
      "publishDate": "2021-09-05 00:00:00.000",
      "infoCode": "AP202109051514339856",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000258545.周平"
      ],
      "indvIsNew": "001",
      "researcher": "周平",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1800,
      "attachPages": 11,
      "encodeUrl": "nMMRskaL6hmXyJp50Wn0NrUeujQXeceXv889/r4IMx8=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHENZHEN",
      "authorID": [
        "11000258545"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "订单获取情况超预期，打好全年高增速基石",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2021-08-29 00:00:00.000",
      "infoCode": "AP202108291513095033",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000182544.魏赟"
      ],
      "indvIsNew": "001",
      "researcher": "魏赟",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 638,
      "attachPages": 5,
      "encodeUrl": "QfbwDhi5zRoKnppiCc3UXw/RwVm/sNE9oOwVeMOxXCY=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000182544"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2021中报点评：主营业务双增长，国际化布局稳步推进",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2021-08-29 00:00:00.000",
      "infoCode": "AP202108281512981843",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 396,
      "attachPages": 4,
      "encodeUrl": "TzlLkn1hnEDomm03ogbt73lpkdT87/S64lt0qE73nBg=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHENZHEN",
      "authorID": [
        "11000177532"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Strong backlog growth driven by solid demand",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80027629",
      "orgName": "CMB International Securities Limited",
      "orgSName": "招银国际",
      "publishDate": "2021-08-27 00:00:00.000",
      "infoCode": "AP202108271512701554",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000305338.Jill Wu",
        "11000324245.Sam HU",
        "11000363832.Jonathan Zhao"
      ],
      "indvIsNew": "001",
      "researcher": "Jill Wu,Sam HU,Jonathan Zhao",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "198.4000000000",
      "indvAimPriceL": "198.4000000000",
      "attachType": "0",
      "attachSize": 997,
      "attachPages": 4,
      "encodeUrl": "vKtTj+E3+/RAtlw65Lb6cHyPzMd8TeEtoTxTzb4F09w=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000305338",
        "11000324245",
        "11000363832"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2021年一季报点评：Q1业绩同比大增，主营业务快速恢复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2021-05-06 00:00:00.000",
      "infoCode": "AP202105061490059260",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000304341.雷国轩"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,雷国轩",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 482,
      "attachPages": 3,
      "encodeUrl": "5H5E7Y4a/XaOHdBXvbdBSZ1XPkkZjj5BK+Ag7o/MEVQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000179188",
        "11000304341"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Q1净利同比增长79%，主业恢复显著，投资收益增厚净利",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2021-04-29 00:00:00.000",
      "infoCode": "AP202104291488647472",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗行业",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "188.0000000000",
      "indvAimPriceL": "188.0000000000",
      "attachType": "0",
      "attachSize": 278,
      "attachPages": 4,
      "encodeUrl": "RVJFO/zVYwGxaLZo4VeiPl7prNO/FGlTIxVeDr/vnME=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80092743",
      "orgName": "华融证券股份有限公司",
      "orgSName": "华融证券",
      "publishDate": "2021-04-09 00:00:00.000",
      "infoCode": "AP202104091483179777",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000206336.张科然"
      ],
      "indvIsNew": "001",
      "researcher": "张科然",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1171,
      "attachPages": 11,
      "encodeUrl": "uJolMG6Tqwx4/vOx3UZyNC9cJEF8SErW/zbH4jdRtNE=",
      "sRatingName": "推荐",
      "sRatingCode": "0102",
      "market": "SHENZHEN",
      "authorID": [
        "11000206336"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩增长符合预期，2021值得期待",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2021-04-01 00:00:00.000",
      "infoCode": "AP202104011480111558",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000279332.马云涛"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,马云涛",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1041,
      "attachPages": 4,
      "encodeUrl": "deZWds/CHGL1RhoMNtZkZO8hVmQ4m10R0CExcHawhzk=",
      "sRatingName": "持有",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000254058",
        "11000279332"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2020年年报点评：临床业务有望快速恢复，巨额合同正待消化",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2021-04-01 00:00:00.000",
      "infoCode": "AP202104011480055741",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000304341.雷国轩"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,雷国轩",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 411,
      "attachPages": 3,
      "encodeUrl": "deZWds/CHGL1RhoMNtZkZNOQmzc3C5mOh6Dr0NM+OZ8=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000179188",
        "11000304341"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "20H2业绩恢复明显，并且在手订单充足，看好公司长远发展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2021-03-31 00:00:00.000",
      "infoCode": "AP202103311479531789",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "188.0000000000",
      "indvAimPriceL": "188.0000000000",
      "attachType": "0",
      "attachSize": 331,
      "attachPages": 4,
      "encodeUrl": "5zlXu44fGWIk5Gr4dYGP7U2zmuXNEisNEp/8/XT5beE=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000210658"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2020年报点评：主营业务平稳增长，国际化进程可期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000197",
      "orgName": "中航证券",
      "orgSName": "中航证券",
      "publishDate": "2021-03-31 00:00:00.000",
      "infoCode": "AP202103311479442662",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000177532.沈文文"
      ],
      "indvIsNew": "001",
      "researcher": "沈文文",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 343,
      "attachPages": 3,
      "encodeUrl": "5zlXu44fGWIk5Gr4dYGP7UdPd3jFLMkNant8kfEmZ3U=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHENZHEN",
      "authorID": [
        "11000177532"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药2020年报点评：疫情恢复良好，在手订单提速",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2021-03-30 00:00:00.000",
      "infoCode": "AP202103301478347578",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000309636.刘慧敏"
      ],
      "indvIsNew": "001",
      "researcher": "刘慧敏",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1082,
      "attachPages": 3,
      "encodeUrl": "cjqdslVTrQGONiaG+Ra8yx54wXRPJ5phVaelZNCEV4s=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000309636"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩略超预期，2021年收入有望保持高速增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2021-03-30 00:00:00.000",
      "infoCode": "AP202103301478316826",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "王睿",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 650,
      "attachPages": 5,
      "encodeUrl": "cjqdslVTrQGONiaG+Ra8y3EJs/L5+gW1tid5h0u3jbU=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000308731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩预告点评报告：业绩符合预期，主业加速恢复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000187",
      "orgName": "万联证券股份有限公司",
      "orgSName": "万联证券",
      "publishDate": "2021-01-29 00:00:00.000",
      "infoCode": "AP202101291455634411",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "2.0500000000",
      "predictLastYearPe": "83.4000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000204123.徐飞",
        "11000354031.宣潇君"
      ],
      "indvIsNew": "001",
      "researcher": "徐飞,宣潇君",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 647,
      "attachPages": 3,
      "encodeUrl": "ShM9U9mud16DVT5SiE/+80D7tudqKzwJlO+1DxzAus8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000204123",
        "11000354031"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Better business recovery outlook in 2021E",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80027629",
      "orgName": "招银国际",
      "orgSName": "招银国际",
      "publishDate": "2021-01-29 00:00:00.000",
      "infoCode": "AP202101291455586676",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.9800000000",
      "predictLastYearPe": "84.7100000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000305338.Jill Wu",
        "11000324245.Sam HU"
      ],
      "indvIsNew": "001",
      "researcher": "Jill Wu,Sam HU",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 862,
      "attachPages": 4,
      "encodeUrl": "ShM9U9mud16DVT5SiE/+863JsvXaHKPcM0klPR3jI8c=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000305338",
        "11000324245"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Further recovery in 3Q",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80027629",
      "orgName": "CMB International Securities Limited",
      "orgSName": "招银国际",
      "publishDate": "2020-11-03 00:00:00.000",
      "infoCode": "AP202011031426081302",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000305338.Jill Wu",
        "11000324245.Sam HU"
      ],
      "indvIsNew": "001",
      "researcher": "Jill Wu,Sam HU",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "146.4300000000",
      "indvAimPriceL": "146.4300000000",
      "attachType": "0",
      "attachSize": 898,
      "attachPages": 4,
      "encodeUrl": "ve6xkzy5I8O8dBHesX90fUhes8sM3tY6YDKPRGeTf0Q=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000305338",
        "11000324245"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩加速恢复，看好公司长期发展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-11-02 00:00:00.000",
      "infoCode": "AP202011021425699133",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000279332.马云涛"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,马云涛",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1090,
      "attachPages": 4,
      "encodeUrl": "+EB0tiRf/fUmMySPIOvCrU+E5RmWHP26LjTGNyF6HF8=",
      "sRatingName": "持有",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000254058",
        "11000279332"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Q3海外业务受疫情拖累，国内业务恢复良好",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2020-11-02 00:00:00.000",
      "infoCode": "AP202011021425569896",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "王睿",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 605,
      "attachPages": 5,
      "encodeUrl": "+EB0tiRf/fUmMySPIOvCrcctUhqWnKdFC42i1BsdaD8=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000308731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药三季报点评：Q3业务进一步恢复，看好行业长期发展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2020-10-31 00:00:00.000",
      "infoCode": "AP202010311425191573",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000238231.常启辉"
      ],
      "indvIsNew": "001",
      "researcher": "常启辉",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1299,
      "attachPages": 3,
      "encodeUrl": "spEQ49uWgPrIxerrNDUo8QfhcEs2nkg0t5kd64mhgOg=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000238231"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2020年三季报点评：临床业务逐步恢复，加速扩张投资版图",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2020-10-30 00:00:00.000",
      "infoCode": "AP202010301424886948",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000304341.雷国轩"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,雷国轩",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 488,
      "attachPages": 3,
      "encodeUrl": "SCu23KxwRxhhHNJRKMIj02FlZ5shx5P9d7k3doQPVfw=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000179188",
        "11000304341"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2020年中报点评：业绩逐步恢复 项目数量持续增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2020-09-01 00:00:00.000",
      "infoCode": "AP202009011406028041",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000182544.魏赟",
        "11000294133.黄施齐"
      ],
      "indvIsNew": "001",
      "researcher": "魏赟,黄施齐",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 828,
      "attachPages": 4,
      "encodeUrl": "1gM9p96zWUG7rhv9pGduxJKNnQm1HPbBzFpMY5kxeLI=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHENZHEN",
      "authorID": [
        "11000182544",
        "11000294133"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "上半年业绩稳定增长，长期看好CRO临床龙头",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2020-08-31 00:00:00.000",
      "infoCode": "AP202008311404547169",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "王睿",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 633,
      "attachPages": 5,
      "encodeUrl": "tUWCCtyzqXeFCxu88finaX5VfqRb68OzYHEMIxWPl54=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000308731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "业绩二季度逐步恢复，下半年有望提速",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-08-31 00:00:00.000",
      "infoCode": "AP202008311404521530",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1088,
      "attachPages": 4,
      "encodeUrl": "tUWCCtyzqXeFCxu88finaRF09pxoEdi1R+OePzVQTsY=",
      "sRatingName": "持有",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000254058"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2020年半年报点评：归母净利润大幅超预期，下半年主营有望修复",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2020-08-31 00:00:00.000",
      "infoCode": "AP202008311404492171",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000304341.雷国轩"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,雷国轩",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 497,
      "attachPages": 3,
      "encodeUrl": "tUWCCtyzqXeFCxu88finaVIFCqIt62qd3XRoTe8h0vY=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000179188",
        "11000304341"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "医药CRO系列报告之泰格医药深度报告：临床明月光，赛道美如舫",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2020-07-02 00:00:00.000",
      "infoCode": "AP202007021388907795",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "727",
      "indvInduName": "医疗服务",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000304341.雷国轩"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,雷国轩",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 4222,
      "attachPages": 46,
      "encodeUrl": "HYbAlqnWnYKAVEH7NArmaSV7FXUNtRXJyH9ZD1tUU5U=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000179188",
        "11000304341"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2020Q1符合预期，二季度蓄力加速",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2020-04-29 00:00:00.000",
      "infoCode": "AP202004291378979564",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000203422.周新明",
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "周新明,王睿",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 364,
      "attachPages": 5,
      "encodeUrl": "vvk5ve++h87mKq+LbpwCooiDqg/xezoJB220x9tlU+0=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000203422",
        "11000308731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药2020Q1业绩点评：疫情影响短期业绩，看好Q2-Q3逐步恢复趋势",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2020-04-29 00:00:00.000",
      "infoCode": "AP202004291378968005",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000324534.郭双喜"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,郭双喜",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 687,
      "attachPages": 5,
      "encodeUrl": "vvk5ve++h87mKq+LbpwCohWOrFKq6QZ5WdhHResb+HQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000324534"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药2020一季报点评：疫情影响逐渐消散，行业有望恢复增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2020-04-29 00:00:00.000",
      "infoCode": "AP202004291378957983",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000238231.常启辉"
      ],
      "indvIsNew": "001",
      "researcher": "常启辉",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 959,
      "attachPages": 3,
      "encodeUrl": "vvk5ve++h87mKq+LbpwColmN6s66GUZ05qoamU1UfDs=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000238231"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "Near term pressure from COVID-19 outbreak won’t hurt long-term growth prospects",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80027629",
      "orgName": "CMB International Securities Limited",
      "orgSName": "招银国际",
      "publishDate": "2020-04-20 00:00:00.000",
      "infoCode": "AP202004201378245150",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000305338.Jill Wu",
        "11000324245.Sam HU",
        "11000272952.Amy Ge"
      ],
      "indvIsNew": "001",
      "researcher": "Jill Wu,Sam HU,Amy Ge",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "87.1800000000",
      "indvAimPriceL": "87.1800000000",
      "attachType": "0",
      "attachSize": 541,
      "attachPages": 5,
      "encodeUrl": "+mCOeq9VFYOOucxYJOK0A4LsP1b5BqVXKAH+3jW/rPg=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000305338",
        "11000324245",
        "11000272952"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年年报点评：营收稳健增长 全球布局完善",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000155",
      "orgName": "上海证券有限责任公司",
      "orgSName": "上海证券",
      "publishDate": "2020-04-20 00:00:00.000",
      "infoCode": "AP202004201378236952",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000182544.魏赟",
        "11000294133.黄施齐"
      ],
      "indvIsNew": "001",
      "researcher": "魏赟,黄施齐",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 809,
      "attachPages": 4,
      "encodeUrl": "+mCOeq9VFYOOucxYJOK0Ax8dgchMQEi9n29+Ipqd6xk=",
      "sRatingName": "增持",
      "sRatingCode": "0203",
      "market": "SHENZHEN",
      "authorID": [
        "11000182544",
        "11000294133"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年年报点评：业绩持续高增长，真实毛利率仍有提升",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2020-04-19 00:00:00.000",
      "infoCode": "AP202004191378216960",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 621,
      "attachPages": 3,
      "encodeUrl": "RhcddeIgE66+XY11GENETyfWq2jLQ7c/JJj8YmW5fyk=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药年报点评：在手订单快速增长，境内业务显著发力",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10001043",
      "orgName": "国元证券股份有限公司",
      "orgSName": "国元证券",
      "publishDate": "2020-04-19 00:00:00.000",
      "infoCode": "AP202004191378216190",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000238231.常启辉"
      ],
      "indvIsNew": "001",
      "researcher": "常启辉",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1301,
      "attachPages": 3,
      "encodeUrl": "RhcddeIgE66+XY11GENET6d9RDkoCooG6buYpXhxIZU=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000238231"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "经营业绩稳健增长，全球化业务布局深化",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2020-04-17 00:00:00.000",
      "infoCode": "AP202004171378185011",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000196764.朱国广",
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广,杜向阳",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1303,
      "attachPages": 10,
      "encodeUrl": "D0XrM0wc7o2RYM9i6Gz2ermUk3uK6TbtU1mzro21lyw=",
      "sRatingName": "持有",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000196764",
        "11000254058"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年年度报告点评：并购整合持续推进，待执行合同同比大增",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2020-04-17 00:00:00.000",
      "infoCode": "AP202004171378184580",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000179188.魏红梅",
        "11000304341.雷国轩"
      ],
      "indvIsNew": "001",
      "researcher": "魏红梅,雷国轩",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 439,
      "attachPages": 3,
      "encodeUrl": "D0XrM0wc7o2RYM9i6Gz2evHUWBJ9wyCP0tkYv64UI68=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHENZHEN",
      "authorID": [
        "11000179188",
        "11000304341"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "年报业绩符合预期，订单持续快速增长",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000134",
      "orgName": "华金证券股份有限公司",
      "orgSName": "华金证券",
      "publishDate": "2020-04-17 00:00:00.000",
      "infoCode": "AP202004171378184577",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000203422.周新明",
        "11000308731.王睿"
      ],
      "indvIsNew": "001",
      "researcher": "周新明,王睿",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 729,
      "attachPages": 5,
      "encodeUrl": "D0XrM0wc7o2RYM9i6Gz2eiPYtRh1x1Wl2GGPHOYza+Q=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000203422",
        "11000308731"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药2019年业绩点评：高景气度仍在持续，自身α拓展有望带来业绩弹性",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2020-04-17 00:00:00.000",
      "infoCode": "AP202004171378155045",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000324534.郭双喜"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,郭双喜",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 415,
      "attachPages": 5,
      "encodeUrl": "D0XrM0wc7o2RYM9i6Gz2ejgR+tJoWR2GDhEP4fp7Kfo=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000324534"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "公司事件点评：子公司业绩良性增长，符合预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2020-04-01 00:00:00.000",
      "infoCode": "AP202004011377332656",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1000000000",
      "predictLastYearPe": "56.7000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建",
        "11000324534.郭双喜"
      ],
      "indvIsNew": "001",
      "researcher": "孙建,郭双喜",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 539,
      "attachPages": 5,
      "encodeUrl": "h2ESqVnzkIbZlR5foBb45WpZYCuHbKQgG+BvnY4pQu8=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684",
        "11000324534"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "To continue strong earnings momentum",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80027629",
      "orgName": "CMB International Securities Limited",
      "orgSName": "招银国际",
      "publishDate": "2020-03-03 00:00:00.000",
      "infoCode": "AP202003031375762102",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1300000000",
      "predictLastYearPe": "67.6300000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000305338.Jill Wu",
        "11000272952.Amy Ge"
      ],
      "indvIsNew": "001",
      "researcher": "Jill Wu,Amy Ge",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "91.8000000000",
      "indvAimPriceL": "91.8000000000",
      "attachType": "0",
      "attachSize": 907,
      "attachPages": 4,
      "encodeUrl": "2l7KN3QzWuFjI4jwLpG/P5VftKvvhA5vtsm6vp9LCI8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHENZHEN",
      "authorID": [
        "11000305338",
        "11000272952"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年业绩快报点评：盈利能力持续改善，关注公司自身α拓展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2020-03-02 00:00:00.000",
      "infoCode": "AP202003021375677962",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1000000000",
      "predictLastYearPe": "67.7000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 658,
      "attachPages": 5,
      "encodeUrl": "zdyv+VmN81EI2gRAJvDf428O8uYYEVdOUvom/QDGgjc=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "非经常损益会计准则变化，扣非后净利润同比增长53.5%，公司业绩符合预期",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2020-03-01 00:00:00.000",
      "infoCode": "AP202003011375670096",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1300000000",
      "predictLastYearPe": "67.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247525.全铭"
      ],
      "indvIsNew": "001",
      "researcher": "全铭",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 402,
      "attachPages": 3,
      "encodeUrl": "z9yDxjkOZ7oWPJ8dhFQAvneUKfd2VzA8J825H/uE3I0=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHENZHEN",
      "authorID": [
        "11000247525"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "公司动态点评：业绩符合预期，三大业务板块值得期待",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000204",
      "orgName": "川财证券有限责任公司",
      "orgSName": "川财证券",
      "publishDate": "2020-03-01 00:00:00.000",
      "infoCode": "AP202002291375660626",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1300000000",
      "predictLastYearPe": "68.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000246940.周豫"
      ],
      "indvIsNew": "001",
      "researcher": "周豫",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 619,
      "attachPages": 3,
      "encodeUrl": "+uH/QbctVbrFeCRSv+vb/k7j9/eMCBfy4BY8cfYIfOM=",
      "sRatingName": "增持",
      "sRatingCode": "0202",
      "market": "SHENZHEN",
      "authorID": [
        "11000246940"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "2019年业绩预告点评：符合预期，关注大临床弹性和α持续拓展",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2020-01-13 00:00:00.000",
      "infoCode": "AP202001131373893995",
      "column": "002004002004",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "1.1300000000",
      "predictLastYearPe": "61.0000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 673,
      "attachPages": 5,
      "encodeUrl": "4jMZG6QyAHNSNnMt+aFs+z+FXVGGbWSbkqOwbM7vmhg=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    },
    {
      "title": "泰格医药公告点评：临床前服务平台布局再加速",
      "stockName": "泰格医药",
      "stockCode": "300347",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2019-12-17 00:00:00.000",
      "infoCode": "AP201912171371886091",
      "column": "002004006003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "0.9400000000",
      "predictLastYearPe": "68.5000000000",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "医药制造",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000180684.孙建"
      ],
      "indvIsNew": "001",
      "researcher": "孙建",
      "newListingDate": "2012-08-17 00:00:00.000",
      "newPurchaseDate": "2012-08-07 00:00:00.0",
      "newIssuePrice": 37.88,
      "newPeIssueA": 44.05,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 664,
      "attachPages": 5,
      "encodeUrl": "dCwdI95lgfldo8InR8Zwn7SzkQMSciVgPLixO5M1BRQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHENZHEN",
      "authorID": [
        "11000180684"
      ],
      "count": 0,
      "orgType": "white"
    }
  ],
  "TotalPage": 5,
  "pageNo": 2,
  "currentYear": 2025
}